Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Gains from Investment Securities (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Gains from Investment Securities for 11 consecutive years, with $27626.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities rose 150.88% to $27626.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $65850.0, a 204.08% increase, with the full-year FY2024 number at $2.7 million, down 17.48% from a year prior.
  • Gains from Investment Securities was $27626.0 for Q3 2025 at KORU Medical Systems, up from $27249.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $135000.0 in Q1 2022 to a low of -$62967.0 in Q4 2023.
  • A 5-year average of $17563.0 and a median of $26797.5 in 2022 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: surged 43608.77% in 2022, then plummeted 335.06% in 2023.
  • KORU Medical Systems' Gains from Investment Securities stood at -$329.0 in 2021, then skyrocketed by 8242.25% to $26788.0 in 2022, then tumbled by 335.06% to -$62967.0 in 2023, then surged by 74.81% to -$15860.0 in 2024, then surged by 274.19% to $27626.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Gains from Investment Securities are $27626.0 (Q3 2025), $27249.0 (Q2 2025), and $26835.0 (Q1 2025).